Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients

ABSTRACT The purpose of this study was to determine the effect of lamotrigine (LTG) and levetiracetam (LEV) as mono- and polytherapy on biochemical markers of bone turnover and bone mineral density in Egyptian adult patients with epilepsy. Methods Forty-eight patients were divided into four groups...

Full description

Saved in:
Bibliographic Details
Main Authors: Sahar Mohamed El-Haggar, Tarek Mohamed Mostafa, Horeya Mohamed Sad Allah, Ghada Hassan Akef
Format: Article
Language:English
Published: Thieme Revinter Publicações
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000700452&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235766939058176
author Sahar Mohamed El-Haggar
Tarek Mohamed Mostafa
Horeya Mohamed Sad Allah
Ghada Hassan Akef
author_facet Sahar Mohamed El-Haggar
Tarek Mohamed Mostafa
Horeya Mohamed Sad Allah
Ghada Hassan Akef
author_sort Sahar Mohamed El-Haggar
collection DOAJ
description ABSTRACT The purpose of this study was to determine the effect of lamotrigine (LTG) and levetiracetam (LEV) as mono- and polytherapy on biochemical markers of bone turnover and bone mineral density in Egyptian adult patients with epilepsy. Methods Forty-eight patients were divided into four groups: two received monotherapy of either LTG or LEV, and the other two groups received polytherapy comprising (valproate [VPA] + LTG or VPA + LEV). Thirty matched healthy participants were included in the study. Participants completed a nutritional and physical activity questionnaire. Biochemical markers of bone and mineral metabolism and bone mineral density of the lumbar spine were measured at baseline and at six months. Results In the LEV monotherapy group, the bone formation markers showed a significant decrease in serum alkaline phosphatase and serum osteocalcin levels while the bone resorption marker showed a significant increase in urinary deoxypyridinoline levels. After six months of treatment, bone mineral density showed a significant decrease in all treated groups, while among monotherapy groups, this significant decrease was more prevalent in the LEV monotherapy group compared with the LTG monotherapy group. Furthermore, there was significant negative correlation between urinary deoxypyridinoline levels and bone mineral density in the LEV monotherapy group. Conclusion Using new generation antiepileptics, LEV monotherapies and polytherapy showed harmful effects on bone but LTG did not.
format Article
id doaj-art-cbcc7b941f9d49018e2a837a360fe0eb
institution OA Journals
issn 1678-4227
language English
publisher Thieme Revinter Publicações
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-cbcc7b941f9d49018e2a837a360fe0eb2025-08-20T02:02:09ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria1678-422776745245810.1590/0004-282x20180068S0004-282X2018000700452Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patientsSahar Mohamed El-HaggarTarek Mohamed MostafaHoreya Mohamed Sad AllahGhada Hassan AkefABSTRACT The purpose of this study was to determine the effect of lamotrigine (LTG) and levetiracetam (LEV) as mono- and polytherapy on biochemical markers of bone turnover and bone mineral density in Egyptian adult patients with epilepsy. Methods Forty-eight patients were divided into four groups: two received monotherapy of either LTG or LEV, and the other two groups received polytherapy comprising (valproate [VPA] + LTG or VPA + LEV). Thirty matched healthy participants were included in the study. Participants completed a nutritional and physical activity questionnaire. Biochemical markers of bone and mineral metabolism and bone mineral density of the lumbar spine were measured at baseline and at six months. Results In the LEV monotherapy group, the bone formation markers showed a significant decrease in serum alkaline phosphatase and serum osteocalcin levels while the bone resorption marker showed a significant increase in urinary deoxypyridinoline levels. After six months of treatment, bone mineral density showed a significant decrease in all treated groups, while among monotherapy groups, this significant decrease was more prevalent in the LEV monotherapy group compared with the LTG monotherapy group. Furthermore, there was significant negative correlation between urinary deoxypyridinoline levels and bone mineral density in the LEV monotherapy group. Conclusion Using new generation antiepileptics, LEV monotherapies and polytherapy showed harmful effects on bone but LTG did not.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000700452&lng=en&tlng=enbone densityepilepsy
spellingShingle Sahar Mohamed El-Haggar
Tarek Mohamed Mostafa
Horeya Mohamed Sad Allah
Ghada Hassan Akef
Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
Arquivos de Neuro-Psiquiatria
bone density
epilepsy
title Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
title_full Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
title_fullStr Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
title_full_unstemmed Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
title_short Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
title_sort levetiracetam and lamotrigine effects as mono and polytherapy on bone mineral density in epileptic patients
topic bone density
epilepsy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000700452&lng=en&tlng=en
work_keys_str_mv AT saharmohamedelhaggar levetiracetamandlamotrigineeffectsasmonoandpolytherapyonbonemineraldensityinepilepticpatients
AT tarekmohamedmostafa levetiracetamandlamotrigineeffectsasmonoandpolytherapyonbonemineraldensityinepilepticpatients
AT horeyamohamedsadallah levetiracetamandlamotrigineeffectsasmonoandpolytherapyonbonemineraldensityinepilepticpatients
AT ghadahassanakef levetiracetamandlamotrigineeffectsasmonoandpolytherapyonbonemineraldensityinepilepticpatients